WINA.NASDAQWinmark CORP

Form 4: Winmark Corp Director Gina DeCaro Sprenger Receives New Stock Option Grant

Sentiment:

Insider Transaction Report


Winmark Corp Director Gina DeCaro Sprenger was granted 280 non-employee stock options with an exercise price of $424.82, vesting over four years.

Summary

  • Gina DeCaro Sprenger, a Director at Winmark Corp (WINA), was granted 280 non-employee stock options on June 1, 2025.
  • The exercise price for these newly granted options is $424.82 per share.
  • These options will vest at a rate of 25% per year over four years, with the first vesting date on June 1, 2026, and an expiration date of June 1, 2035.
  • The filing also details existing stock option holdings of Ms. Sprenger, including 10,000 options at $182.21, 750 at $195.82, 750 at $261.32, 880 at $197.80, 620 at $238.60, 380 at $325.99, 240 at $446.68, 300 at $355.90, and 300 at $400.97.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is generally a positive signal of continued commitment and alignment, but it's a routine compensation event rather than a significant operational or financial announcement. The value is neutral to slightly positive.

Positives

  • The grant of new stock options to a director indicates continued alignment of management's interests with shareholder value.
  • The options have a vesting schedule (25% per year for four years), encouraging long-term commitment from the director.

Negatives

  • No specific negative financial or operational information is presented in this Form 4 filing.

Risks

  • The value of the stock options is subject to the future performance of Winmark Corp's stock price, meaning they could become worthless if the stock price falls below the exercise price.
  • Potential for minor dilution exists if a significant number of options are exercised, although the number granted in this filing is relatively small.

Future Outlook

The document does not provide a future outlook for the company's financial performance or strategic direction, focusing solely on an insider's equity transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity transaction. It reflects a common practice of compensating non-employee directors with stock options to align their interests with long-term shareholder value. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

  • The grant of stock options to non-employee directors is a standard practice across many industries, including the retail and franchising sector where Winmark Corp operates.
  • The specific number of options (280) and the exercise price ($424.82) would need to be compared against peer companies' director compensation packages to assess if it's above, below, or in line with industry averages. Without specific peer data, a detailed comparison is not possible from this document alone.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationGrant of 280 non-employee stock options to Director Gina DeCaro Sprenger as part of her compensation package, aligning her interests with shareholder value.06/01/2025Reinforces director's long-term commitment and incentivizes performance tied to stock appreciation.

Stakeholder Impact

  • Shareholders: The grant of options aligns the director's interests with shareholders, as the options gain value only if the stock price increases. However, it also represents potential future dilution upon exercise.

Next Steps

  • The newly granted options will begin vesting at 25% per year starting June 1, 2026.
  • The options will expire on June 1, 2035, if not exercised.

Key Dates

DateDescription
01/13/2022Date of grant for 10,000 non-employee stock options with an exercise price of $182.21, expiring 01/13/2031.
06/01/2022Date of grant for 750 non-employee stock options with an exercise price of $195.82, expiring 06/01/2031.
12/13/2022Date of grant for 750 non-employee stock options with an exercise price of $261.32, expiring 12/13/2031.
06/01/2023Date of grant for 880 non-employee stock options with an exercise price of $197.80, expiring 06/01/2032.
12/12/2023Date of grant for 620 non-employee stock options with an exercise price of $238.60, expiring 12/12/2032.
06/01/2024Date of grant for 380 non-employee stock options with an exercise price of $325.99, expiring 06/01/2033.
12/11/2024Date of grant for 240 non-employee stock options with an exercise price of $446.68, expiring 12/11/2024.
06/01/2025Date of grant for 280 new non-employee stock options with an exercise price of $424.82, vesting 25% annually for four years starting 06/01/2026, and expiring 06/01/2035.
06/01/2025Date of grant for 300 non-employee stock options with an exercise price of $355.90, expiring 06/01/2034.
06/02/2025Signature date of Gina DeCaro Sprenger for the Form 4 filing.
12/09/2025Date of grant for 300 non-employee stock options with an exercise price of $400.97, expiring 12/09/2034.

Keywords

Winmark Corp, WINA, SEC Form 4, Stock Options, Insider Transaction, Director Compensation, Beneficial Ownership, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.